ArticlePediatric cardiology2026
Initial Experience of the Medtronic Aurora Extravascular Implantable Cardioverter in Children in a UK Centre.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Extravascular Implantable Cardioverter-Defibrillator Therapy for Malignant Ventricular Arrhythmias in a Child with Congenital Long QT Syndrome: A Case Report.Journal of cardiovascular development and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Implantation of an implantable cardioverter-defibrillator (ICD) in childhood comes with many challenges due to implantation of a device early in life, the small patient size and ongoing growth. The Aurora EV-ICD is the smallest extravascular device with a novel implantation technique. Implantation of the Aurora EV-ICD was performed in three paediatric patients in our institution between September 2024 and February 2025. The ages of the patients were 6, 12 and 16 years. The weight range was 20 to 45 kg, and the height range was 121 to 161 cm. The procedure was performed under general anaesthesia. The implantation was uneventful in all cases. A 52 cm EV2401 lead was implanted using the provided tunnelling tool with excellent sensing and pacing parameters. The Aurora EV-ICD
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.